|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Select Publications
Di Leo A et al. Lapatinib (L) with paclitaxel compared to paclitaxel as first-line treatment for patients with metastatic breast cancer: A Phase III randomized, double-blind study of 580 patients. Proc ASCO 2007;Abstract 1011.
Gradishar WJ et al. Randomized comparison of weekly or every-3-week (q3w) nab-paclitaxel compared to q3w docetaxel as first-line therapy in patients (pts) with metastatic breast cancer (MBC). Proc ASCO 2007;Abstract 1032.
Miller K et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 2007;357(26):2666-76. Abstract
 |
 |
EDITOR
Neil Love, MD
TOPICS
Treatment of Early Breast Cancer
- Select publications
Treatment of Metastatic Breast Cancer
- Select publications
Breast Cancer Update - Think Tank:
A CME Audio Series and Activity
 |
 |
 |
 |
 |
